Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia

Includes bibliographical references (leaves 133-147)

Saved in:
Bibliographic Details
Main Author: Ghebremariam, Yohannes T
Other Authors: Kotwal, Girish J
Format: Thesis
Language:English
Published: Division of Virology 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613289305866240
access_status_str Open Access
author Ghebremariam, Yohannes T
author2 Kotwal, Girish J
author_browse Ghebremariam, Yohannes T
Kotwal, Girish J
author_facet Kotwal, Girish J
Ghebremariam, Yohannes T
author_sort Ghebremariam, Yohannes T
collection Thesis
description Includes bibliographical references (leaves 133-147)
format Thesis
id oai:open.uct.ac.za:11427/2726
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:33:45.686Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Division of Virology
publisherStr Division of Virology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/2726 Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia Ghebremariam, Yohannes T Kotwal, Girish J Kahn, Del Medical Virology Includes bibliographical references (leaves 133-147) In transplantation, vascularized organs often suffer the consequences of ischemic damage as well as reperfusion injury following the reestablishment of blood flow. The induced ischemialreperfusion (I/R) damage is usually associated with the accumulation of injurious complement components. The vaccinia virus complement control protein (VCP) has the ability to simultaneously inhibit the classical and the alternative complement pathways by binding to the early components C3b and C4b. The complement component C3 is known to be the central route to all of the known complement activation pathways. As a result, it is involved in a number of complement-mediated ailments including renal ischemia/reperfusion injury. The objectives of this study were to initially evaluate the in vitro roles of the natural VCP and the humanized recombinant VCP (hrVCP), and then to establish their in vivo roles in a renal I/R injury model. 2014-07-28T08:19:13Z 2014-07-28T08:19:13Z 2006 Doctoral Thesis Doctoral PhD http://hdl.handle.net/11427/2726 eng application/pdf Division of Virology Faculty of Health Sciences University of Cape Town
spellingShingle Medical Virology
Ghebremariam, Yohannes T
Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
thesis_degree_str Doctoral
title Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
title_full Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
title_fullStr Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
title_full_unstemmed Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
title_short Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
title_sort evaluation of the in vivo role of vaccinia virus complement control protein vcp following renal ischemia
topic Medical Virology
url http://hdl.handle.net/11427/2726
work_keys_str_mv AT ghebremariamyohannest evaluationoftheinvivoroleofvacciniaviruscomplementcontrolproteinvcpfollowingrenalischemia